This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Injectable Drugs Market

Market Insights on Injectable Drugs covering sales outlook, demand forecast & up-to-date key trends

Injectable Drugs Market By Product, Application, Molecule Type, Route of Administration, Distribution Channel & Region - Forecast 2022 – 2032

Injectable Drugs Market Outlook (2022-2032)

[341 Pages Report] The global injectable drugs market is expected to reach US$ 531.8 Bn in 2022. Sales in the market will increase at a CAGR of 5.8%, reaching US$ 937.0 Bn by 2032. According to a recent study by Future Market Insights, large molecules for injectable drugs are leading the market with a share of about 51.8% in the year 2021.

Data Points

Market Insights

Injectable Drugs Market Base Year Value (2021)

US$ 501.8 Bn

Estimated Market Size (2022)

US$ 531.8 Bn

Projected Market Valuation (2032)

US$ 937 Bn

Value-based CAGR (2022-2032)

5.8%

Market Share of Top 5 Countries

53.8%

Customize this Report

Let us know your requirement to get
100% FREE customization

2014-2021 Injectable Drugs Market Historic Outlook Vs 2022-2032 Forecast

Demand in the global injectable drugs market grew at a CAGR of 4.1% between 2014 to 2021.

Injectable routes are alternative methods for drug administration other than the oral/digestive route. The injectable route of drug administration helps avoid errors during the hospital stay of a patient. Injectable drugs assist with greater absorption of drugs into the system and aid with a quicker recovery time.

The demand for injectable drugs is increasing as the need to provide better patient outcomes has been on the rise. The method has been useful in emergency cases when oral drug delivery is restricted. Rapid absorption and faster drug action, lower risk of drug degradation by gastric secretion, and less concentration of the drug are some of the main factors expected to boost demand in the market.

Rising burden of infectious diseases, oncology diseases, and cardiovascular diseases, is driving demand for effective treatment solutions across the globe, which is expected to boost sales of injectable drugs at a 5.8% CAGR over the forecast period.

Injectable Drugs Market Download Report Brochure

Which Factors are Driving Demand for Injectable Drugs?

The proportion of drugs in the pipeline requiring injectable administration has increased. This is primarily due to the rise in the production and availability of biological drugs in the global healthcare market.

The intravenous route provides easy absorption of the drugs into the blood, thus enhancing patient satisfaction. This is expected to spur demand for injectable drugs over the forecast period.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What is Restraining the Growth in the Injectable Drugs Market?

Injectable drugs require complex equipment for manufacturing, each of which needs proper certification and sterilization before production. This leads to high operating costs as well as a high level of debts due to the purchase/ rent-to-lease of the capital equipment.

Additionally, the regulatory cost burden is high owing to the FDA mandates for maintaining an appropriate degree of care, not only in manufacturing, but also in packaging, storage, and distribution processes.

Maintenance of sterility against bacterial and fungal contamination, stability difficulties (crystallization), separation of extractable and leachable compounds from packing materials such as glass, metal, or fibers in vials, and transportation and logistics, are some examples of high-cost consumption.

Country-wise Insights

What is the U.S. Injectable Drugs Market Outlook?

“Increasing Investments in the Healthcare Sector Will Boost Sales of Injectable Drugs”

The U.S. accounted for about 92.1% of the North America injectable drugs market in 2021, owing to the development of many novel drugs, and rising government investments in the healthcare sector.

Moreover, approvals by the U.S. FDA are increasing resulting in more products being launched, making the U.S an attractive market. For example, Merck reported in December 2021 that the FDA had granted Priority Review to the company's application for VAXNEUVANCE for the prevention of invasive pneumococcal disease in children aged 6 weeks to 17 years.

In addition, rising awareness about therapeutically advanced management of diseases will create opportunities for growth in the market in the forthcoming years.

What is Driving the Germany Injectable Drugs Market?

“Growing Trend of Medical Tourism in Germany Will Spur Demand for Injectable Drugs”

Germany accounted for around 20.5% market share in the Europe injectable drugs market in 2021, and the trend is expected to continue over the forecast period.

As the burden of chronic diseases increases in Europe, the European Generics Medicine Association (EGA) has made it their goal to provide essential medicines to patients within the region. They are adding biosimilars medicine into their portfolio to deliver high patient outcomes.

As oncological diseases and other chronic and rare diseases are on the rise, improvements in the health infrastructure have also been a priority. These measures have led to a rise in the number of established ambulatory health centers, where treatments can be provided without the admission of the patient. This has led to an increase in the sales of monoclonal antibodies as treatments to be carried out in ambulatory centers. Such developments are expected to bode well for the Germany market.

Which Factors are Fueling Demand for the Injectable Drugs in China?

“Rapid Expansion in the Pharmaceutical Sector in China Will Fuel Sales of Injectable Drugs”

China accounted for around 43.1% of the East Asia injectable drugs market in 2021. Some of the important factors driving market expansion in China are the availability of major manufacturing services to fulfill clinical needs, increasing prevalence of chronic illnesses, and high production of raw materials for drug manufacturing.

Furthermore, the CFDA has enforced improved pharmaceutical production quality and encouraged the approval of novel drugs. China is projected to account for the largest share in the East Asia injectable drugs market due to its cost-effective pharmaceutical production.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Category-wise Insights

Which Product in the Injectable Drugs Market is Gaining Traction?

“Demand for Monoclonal Antibodies to Remain High”

By product, sales in the monoclonal antibodies segment are expected to increase at a 9.3% CAGR over the forecast period. This is influenced by increasing research & development, expansion, and manufacturing of the injectable drugs market.

For example, Baxter International Inc. announced a $100 million addition to its sterile fill/finish production plant in Halle/Westfalen, Germany, in November 2021. The new production building is scheduled to begin being constructed in 2022 and be completed in 2024.

Furthermore, the injectable route of administration of drugs has been very effective in an emergency where a patient fails to respond/restricts the oral treatment. By route of administration, the intravenous route had a market share of 50.7% in 2021 with a CAGR of 5.3%, thus driving the demand for injectable drugs during the forecast period.

Which Application is Large of Focus within the Injectable Drugs Market?

“Adoption of Injectable Drugs for the Treatment of Infectious Diseases Will Gain Traction”

In terms of applications, sales in the infectious diseases segment are slated to surge at a 5.7% CAGR over the assessment period. With the rising rate of infection proliferation, the market for injectable drugs faces a high inclination in production, as per global demand. Thus, the growing prevalence of infectious diseases is set to promote the overall revenue sales of the injectable drugs market over the forecast period.  

Which Molecule Type is Driving the Injectable Drugs Market?

“Large Molecule Injectable Drugs are More Preferred”

Large molecules, often known as biologics, are proteins that have a therapeutic impact. Most large molecule drugs, in contrast to small molecule drug products, are complex, comprising over 1,300 amino acids, and are identical analogs of human proteins.

The large molecules segment held around 51.8% of the total market share in 2021, and the segment is set to expand at a CAGR rate of 7.6% during the forecast period.

Competitive Landscape

Key manufacturers in the injectable drugs market space are focusing on the expansion of their portfolios by introducing new and technologically advanced products, taking continuous initiatives in getting new product approvals, and employing acquisitions as a strategy to maintain their position in the global injectable drugs market. For instance:

  • In March 2022, Pfizer Inc. announced its acquisition of Arena Pharmaceuticals for the treatment of numerous immuno-inflammatory diseases.
  • In March 2022, Sanofi and Seagen Inc. signed an exclusive collaboration agreement for the design, development, and commercialization of antibody-drug conjugates (ADCs) for up to three cancer targets.

Report Scope as per Injectable Drugs Industry Analysis

Attribute

Details

Estimated Market Size (2022)

US$ 538.1 Bn

Projected Market Valuation (2032)

US$ 937 Bn

Value-based CAGR (2022-2032)

5.8%

Forecast Period

2014-2021

Historical Data Available for

2022-2032

Market Analysis

US$ Bn for Value

Key Regions Covered

North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa

Key Countries Covered

The U.S., Canada, Brazil, Mexico, Argentina, the U.K., Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Malaysia, Japan, China, South Korea, Australia, New Zealand, GCC Countries, and South Africa

Key Market Segments Covered

Product, Application, Molecule Type, Route of Administration, Distribution Channel, and Region

Key Companies Profiled

  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd.
  • AstraZeneca Plc
  • Merck & Co., Inc.
  • Viatris + Mylan N.V
  • Cipla Inc.
  • Dr. Reddy’s Laboratories Ltd.
  • Samsung Biologics
  • Abbott Laboratories
  • Amgen Incorporated
  • Baxter International Incorporated
  • Becton Dickinson and Company
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline Plc
  • Roche Holding Limited

Key Segments Covered in Injectable Drugs Industry Research

By Product:

  • Monoclonal Antibodies
  • Immunoglobulin
  • Cytokines
  • Insulin
  • Peptide Hormones
  • Blood Factors
  • Peptide Antibiotics
  • Vaccines
  • Small Molecule Antibiotics
  • Chemotherapy Agents
  • Others

By Application:

  • Oncology
  • Infectious Diseases
  • Diabetes
  • Blood disorders
  • Hormonal Disorders
  • Musculoskeletal Disorders
  • CNS Diseases
  • Pain Management
  • Cardiovascular Diseases

By Molecule Type:

  • Small Molecules
  • Large Molecules

By Route of Administration:

  • Intravenous (IV)
  • Intramuscular (IM)
  • Subcutaneous (SC)

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East and Africa (MEA)

Frequently Asked Questions

The global injectable drugs market was worth US$ 501.8 Bn in 2021.

The global market for injectable drugs is expected to reach US$ 937.0 Bn by the end of 2032.

Revenue from the injectable drugs market increased at a CAGR of 4.1% from 2014 to 2021.

The U.S., China, Japan, Germany, and U.K. are driving the most growth in the global injectable drugs market.

The U.S. accounted for a 92.1% share of the North American market in 2021.

The Europe injectable drugs market is predicted to expand at a 5.8% CAGR over the forecast period.

Top companies in this market are Pfizer Inc., Roche Holding Limited, Novartis, Merck & Co., Inc., Bristol-Myers Squibb Company, GlaxoSmithKline Plc, AstraZeneca Plc, Amgen Incorporated, Becton, Dickinson and Company, Viatris + Mylan N.V, Teva Pharmaceutical Industries Ltd., Baxter International Incorporated, Sun Pharmaceutical Industries Ltd., and Cipla Inc.

The South Korean injectable drugs market is expected to exhibit a 4.3% CAGR, with the Japanese market expected to grow at a lucrative pace with a CAGR value of around 6.7% during the forecast period.

Table of Content

1. Global Market - Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supple Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Definition and Introduction

    2.2. Market Taxonomy/ Research Scope

    2.3. Inclusions & Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Key Success Factors

    4.1. Disease Epidemiology

    4.2. Pipeline Analysis

    4.3. Regulatory Scenario

    4.4. Promotional Strategies, By Key Manufacturers

    4.5. Supply chain Analysis

    4.6. PESTEL Analysis

    4.7. PORTER Analysis

    4.8. Number of Clinical Trial

    4.9. List of Manufacturers

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP Growth Outlook

        5.1.2. Rising per-Capita Healthcare Expenditure

        5.1.3. Generic Versions Intensify Total Sale

        5.1.4. Plant Upgrades Pushing Pricing of Injectable Drugs

        5.1.5. Favorable Reimbursement Scenario Fuels the Market Growth

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Product Cost

        5.2.2. Frequency of Product Lunches 

        5.2.3. Per Patient Spending

        5.2.4. Product Awareness

        5.2.5. Products in Pipeline 

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. COVID19 Crisis Analysis

    6.1. Current COVID19 Statistics and Probable Future Impact

    6.2. Current GDP Projection and Probable Impact

    6.3. Current Economic Projection as compared to 2008 financial analysis

    6.4. COVID19 and Impact Analysis

        6.4.1. Revenue By Product

        6.4.2. Revenue By Application

        6.4.3. Revenue By Molecule

        6.4.4. Revenue By Route of Administration

        6.4.5. Revenue By Distribution Channel

    6.5. 2020 Market Scenario

7. Global Market Value (US$ Bn) Analysis 2014-2021 and Forecast, 2022-2032

    7.1. Historical Market Value (US$ Bn) Analysis, 2014-2021

    7.2. Current and Future Market Value (US$ Bn) Projections, 2022-2032

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2014-2021 and Forecast 2022-2032, By Product 

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Bn) Analysis By Product , 2014-2021

    8.3. Current and Future Market Size (US$ Bn) Analysis Forecast By Product, 2022-2032

        8.3.1. Monoclonal Antibodies

        8.3.2. Immunoglobulin

        8.3.3. Cytokines

        8.3.4. Insulin

        8.3.5. Peptide Hormones

        8.3.6. Blood Factors

        8.3.7. Peptide Antibiotics

        8.3.8. Vaccines

        8.3.9. Small Molecule Antibiotics

        8.3.10. Chemotherapy Agents

        8.3.11. Others

    8.4. Market Attractiveness Analysis By Product 

9. Global Market Analysis 2014-2021 and Forecast 2022-2032, By Application  

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Bn) Analysis By Application , 2014-2021

    9.3. Current and Future Market Size (US$ Bn) Analysis Forecast By Application , 2022-2032

            9.3.1.1. Oncology

            9.3.1.2. Infectious Diseases

            9.3.1.3. Diabetes

            9.3.1.4. Blood disorders

            9.3.1.5. Hormonal Disorders

            9.3.1.6. Musculoskeletal Disorders

            9.3.1.7. CNS Diseases

            9.3.1.8. Pain Management

            9.3.1.9. Cardiovascular Diseases

    9.4. Market Attractiveness Analysis By Application 

10. Global Market Analysis 2014-2021 and Forecast 2022-2032, By Molecule Type 

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Bn) Analysis By Molecule Type, 2014-2021

    10.3. Current and Future Market Size (US$ Bn) Analysis Forecast By Molecule Type, 2022-2032

            10.3.1.1. Small Molecule

            10.3.1.2. Large Molecule

    10.4. Market Attractiveness Analysis By Distribution Channel

11. Global Market Analysis 2014-2021 and Forecast 2022-2032, By Route of Administration 

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Bn) Analysis By Route of Administration, 2014-2021

    11.3. Current and Future Market Size (US$ Bn) Analysis Forecast By Route of Administration, 2022-2032

            11.3.1.1. Intravenous

            11.3.1.2. Intramuscular

            11.3.1.3. Subcutaneous 

    11.4. Market Attractiveness Analysis By Route of Administration

12. Global Market Analysis 2014-2021 and Forecast 2022-2032, By Distribution Channel 

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Bn) Analysis By Distribution Channel, 2014-2021

    12.3. Current and Future Market Size (US$ Bn) Analysis Forecast By Distribution Channel, 2022-2032

            12.3.1.1. Hospital Pharmacies

            12.3.1.2. Retail Pharmacies

            12.3.1.3. Drug Stores

            12.3.1.4. Online Pharmacies

    12.4. Market Attractiveness Analysis By Distribution Channel

13. Global Market Analysis 2014-2021 and Forecast 2022-2032, By Region

    13.1. Introduction

    13.2. Historical Market Size (US$ Bn) Analysis By Region, 2014-2021

    13.3. Current and Future Market Size (US$ Bn) Analysis Forecast By Region, 2022-2032

        13.3.1. North America

        13.3.2. Latin America

        13.3.3. Europe

        13.3.4. South Asia

        13.3.5. East Asia

        13.3.6. Oceania

        13.3.7. Middle East & Africa 

    13.4. Market Attractiveness Analysis By Region

14. North America Market Analysis 2014-2021 and Forecast 2022-2032

    14.1. Introduction

    14.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2014-2021

    14.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2022 - 2032

        14.3.1. By Country

            14.3.1.1. US

            14.3.1.2. Canada

        14.3.2. By Product

        14.3.3. By Application

        14.3.4. By Molecule Type

        14.3.5. Route of administration

        14.3.6. By Distribution Channel

    14.4. Market Attractiveness Analysis

        14.4.1. By Product

        14.4.2. By Application

        14.4.3. By Molecule Type

        14.4.4. Route of administration

        14.4.5. By Distribution Channel

    14.5. Key Market Participants - Intensity Mapping

    14.6. Drivers and Restraints - Impact Analysis

    14.7. Country Level Analysis & Forecast

        14.7.1. U.S. Market 

            14.7.1.1. Introduction

            14.7.1.2. Market Analysis and Forecast by Market Taxonomy

                14.7.1.2.1. By Product

                14.7.1.2.2. By Application

                14.7.1.2.3. By Molecule Type

                14.7.1.2.4. Route of administration

                14.7.1.2.5. By Distribution Channel

        14.7.2. Canada Market 

            14.7.2.1. Introduction

            14.7.2.2. Market Analysis and Forecast by Market Taxonomy

                14.7.2.2.1. By Product

                14.7.2.2.2. By Application

                14.7.2.2.3. By Molecule Type

                14.7.2.2.4. Route of administration

                14.7.2.2.5. By Distribution Channel

15. Latin America Market Analysis 2014-2021 and Forecast 2022-2032

    15.1. Introduction

    15.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2014-2021

    15.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2022 - 2032

        15.3.1. By Country

            15.3.1.1. Brazil

            15.3.1.2. Mexico

            15.3.1.3. Argentina

            15.3.1.4. Rest of Latin America

        15.3.2. By Product

        15.3.3. By Application

        15.3.4. By Molecule Type

        15.3.5. Route of administration

        15.3.6. By Distribution Channel

    15.4. Market Attractiveness Analysis

        15.4.1. By Product

        15.4.2. By Application

        15.4.3. By Molecule Type

        15.4.4. Route of administration

        15.4.5. By Distribution Channel

    15.5. Key Market Participants - Intensity Mapping

    15.6. Drivers and Restraints - Impact Analysis

    15.7. Country Level Analysis & Forecast

        15.7.1. Brazil Market 

            15.7.1.1. Introduction

            15.7.1.2. Market Analysis and Forecast by Market Taxonomy

                15.7.1.2.1. By Product

                15.7.1.2.2. By D By Application

                15.7.1.2.3. By Molecule Type

                15.7.1.2.4. Route of administration distribution Channel

        15.7.2. Argentina Market

            15.7.2.1. Introduction

            15.7.2.2. Market Analysis and Forecast by Market Taxonomy

                15.7.2.2.1. By Product

                15.7.2.2.2. By Application

                15.7.2.2.3. By Molecule Type

                15.7.2.2.4. Route of administration

                15.7.2.2.5. Distribution Channel

        15.7.3. Mexico Market 

            15.7.3.1. Introduction

            15.7.3.2. Market Analysis and Forecast by Market Taxonomy

                15.7.3.2.1. By Product

                15.7.3.2.2. B By Application

                15.7.3.2.3. By Molecule Type

                15.7.3.2.4. Route of administration

                15.7.3.2.5. Distribution Channel

16. Europe Market Analysis 2014-2021 and Forecast 2022-2032

    16.1. Introduction

    16.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2014-2021

    16.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2022 - 2032

        16.3.1. By Country

            16.3.1.1. Germany

            16.3.1.2. Italy

            16.3.1.3. France

            16.3.1.4. U.K.

            16.3.1.5. Spain

            16.3.1.6. BENELUX

            16.3.1.7. Russia

            16.3.1.8. Rest of Europe

                16.3.1.8.1. By Product 

                16.3.1.8.2. By Application

                16.3.1.8.3. By Molecule Type

                16.3.1.8.4. Route of administration

                16.3.1.8.5. By Distribution Channel

    16.4. Market Attractiveness Analysis

        16.4.1. By Product 

        16.4.2. By Application

        16.4.3. By Molecule Type

        16.4.4. Route of administration

        16.4.5. By Distribution Channel

    16.5. Country Level Analysis & Forecast

        16.5.1. Germany Market

            16.5.1.1. Introduction

            16.5.1.2. Market Analysis and Forecast by Market Taxonomy

                16.5.1.2.1. By Product 

                16.5.1.2.2. By Application

                16.5.1.2.3. By Molecule Type

                16.5.1.2.4. Route of administration

                16.5.1.2.5. By Distribution Channel

        16.5.2. Italy Market 

            16.5.2.1. Introduction

            16.5.2.2. Market Analysis and Forecast by Market Taxonomy

                16.5.2.2.1. By Product 

                16.5.2.2.2. By Application

                16.5.2.2.3. By Molecule Type

                16.5.2.2.4. Route of administration

                16.5.2.2.5. By Distribution Channel

        16.5.3. France Market

            16.5.3.1. Introduction

            16.5.3.2. Market Analysis and Forecast by Market Taxonomy

                16.5.3.2.1. By Product 

                16.5.3.2.2. By Application

                16.5.3.2.3. By Molecule Type

                16.5.3.2.4. Route of administration

                16.5.3.2.5. By Distribution Channel

        16.5.4. U.K.  Injectable Drugs Market

            16.5.4.1. Introduction

            16.5.4.2. Market Analysis and Forecast by Market Taxonomy

                16.5.4.2.1. By Product  

                16.5.4.2.2. By Application

                16.5.4.2.3. By Molecule Type

                16.5.4.2.4. Route of administration

                16.5.4.2.5. By Distribution Channel

        16.5.5. Spain Market

            16.5.5.1. Introduction

            16.5.5.2. Market Analysis and Forecast by Market Taxonomy

            16.5.5.3. By Product 

            16.5.5.4. By Application

            16.5.5.5. By Molecule Type

            16.5.5.6. Route of administration

            16.5.5.7. By Distribution Channel

        16.5.6. BENELUX Market

            16.5.6.1. Introduction

            16.5.6.2. Market Analysis and Forecast by Market Taxonomy

                16.5.6.2.1. By Product 

                16.5.6.2.2. By Application

                16.5.6.2.3. By Molecule Type

                16.5.6.2.4. Route of administration

                16.5.6.2.5. By Distribution Channel

        16.5.7. Russia Market

            16.5.7.1. Introduction

            16.5.7.2. Market Analysis and Forecast by Market Taxonomy

                16.5.7.2.1. By Product 

                16.5.7.2.2. By Application

                16.5.7.2.3. By Molecule Type

                16.5.7.2.4. Route of administration

                16.5.7.2.5. By Distribution Channel

17. South Asia Market Analysis 2014-2021 and Forecast 2022-2032

    17.1. Introduction

    17.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2014-2021

    17.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2022 - 2032

        17.3.1. By Country

            17.3.1.1. India

            17.3.1.2. Thailand

            17.3.1.3. Malaysia

            17.3.1.4. Rest Of South Asia

                17.3.1.4.1. By Product 

                17.3.1.4.2. By Application

                17.3.1.4.3. By Molecule Type

                17.3.1.4.4. Route of administration

                17.3.1.4.5. By Distribution Channel

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Product 

        17.4.3. By Application

        17.4.4. By Molecule Type

        17.4.5. Route of administration

        17.4.6. By Distribution Channel

    17.5. Country Level Analysis & Forecast

        17.5.1. India Market

            17.5.1.1. Introduction

            17.5.1.2. Market Analysis and Forecast by Market Taxonomy

                17.5.1.2.1. By Product

                17.5.1.2.2. By Application

                17.5.1.2.3. By Molecule Type

                17.5.1.2.4. Route of administration

                17.5.1.2.5. By Distribution Channel

        17.5.2. Thailand Market

            17.5.2.1. Introduction

            17.5.2.2. Market Analysis and Forecast by Market Taxonomy

                17.5.2.2.1. By Product 

                17.5.2.2.2. By Application

                17.5.2.2.3. By Molecule Type

                17.5.2.2.4. Route of administration

                17.5.2.2.5. By Distribution Channel

        17.5.3. Malaysia Market

            17.5.3.1. Introduction

            17.5.3.2. Market Analysis and Forecast by Market Taxonomy

                17.5.3.2.1. By Product 

                17.5.3.2.2. By Application

                17.5.3.2.3. By Molecule Type

                17.5.3.2.4. Route of administration

                17.5.3.2.5. By Distribution Channel

18. East Asia Market Analysis 2014-2021 and Forecast 2022-2032

    18.1. Introduction

    18.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2014-2021

    18.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2022 - 2032

        18.3.1. By Country

            18.3.1.1. China

            18.3.1.2. Japan

            18.3.1.3. South Korea

                18.3.1.3.1. By Product 

                18.3.1.3.2. By Application

                18.3.1.3.3. By Molecule Type

                18.3.1.3.4. Route of administration

                18.3.1.3.5. By Distribution Channel

    18.4. Market Attractiveness Analysis

        18.4.1. By Country

        18.4.2. By Product 

        18.4.3. By Application

        18.4.4. By Molecule Type

        18.4.5. Route of administration

        18.4.6. By Distribution Channel

    18.5. Country Level Analysis & Forecast

        18.5.1. China Market

            18.5.1.1. Introduction

            18.5.1.2. Market Analysis and Forecast by Market Taxonomy

                18.5.1.2.1. By Product 

                18.5.1.2.2. By Application

                18.5.1.2.3. By Molecule Type

                18.5.1.2.4. Route of administration

                18.5.1.2.5. By Distribution Channel

        18.5.2. Japan Market

            18.5.2.1. Introduction

            18.5.2.2. Market Analysis and Forecast by Market Taxonomy

                18.5.2.2.1. By Product 

                18.5.2.2.2. By Application

                18.5.2.2.3. By Molecule Type

                18.5.2.2.4. Route of administration

                18.5.2.2.5. By Distribution Channel

        18.5.3. South Korea Market

            18.5.3.1. Introduction

            18.5.3.2. Market Analysis and Forecast by Market Taxonomy

                18.5.3.2.1. By Product 

                18.5.3.2.2. By Application

                18.5.3.2.3. By Molecule Type

                18.5.3.2.4. Route of administration

                18.5.3.2.5. By Distribution Channel

19. Oceania Market Analysis 2014-2021 and Forecast 2022-2032

    19.1. Introduction

    19.2. Historical Market Size (US$ Bn)  and Trend Analysis By Market Taxonomy, 2014-2021

    19.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2022 - 2032

        19.3.1. By Country

            19.3.1.1. Australia

            19.3.1.2. New Zealand

                19.3.1.2.1. By Product 

                19.3.1.2.2. By Application

                19.3.1.2.3. By Molecule Type

                19.3.1.2.4. Route of administration

                19.3.1.2.5. By Distribution Channel

    19.4. Market Attractiveness Analysis

        19.4.1. By Country

        19.4.2. By Product 

        19.4.3. By Application

        19.4.4. By Molecule Type

        19.4.5. Route of administration

        19.4.6. By Distribution Channel

    19.5. Country Level Analysis & Forecast

        19.5.1. Australia Market

            19.5.1.1. Introduction

            19.5.1.2. Market Analysis and Forecast by Market Taxonomy

                19.5.1.2.1. By Product 

                19.5.1.2.2. By Application

                19.5.1.2.3. By Molecule Type

                19.5.1.2.4. Route of administration

                19.5.1.2.5. By Distribution Channel

        19.5.2. New Zealand Market

            19.5.2.1. Introduction

            19.5.2.2. Market Analysis and Forecast by Market Taxonomy

                19.5.2.2.1. By Product 

                19.5.2.2.2. By Application

                19.5.2.2.3. By Molecule Type

                19.5.2.2.4. Route of administration

                19.5.2.2.5. By Distribution Channel

20. MEA Market Analysis 2014-2021 and Forecast 2022-2032

    20.1. Introduction

    20.2. Historical Market Size (US$ Bn)  and Trend Analysis By Market Taxonomy, 2014-2021

    20.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2022 - 2032

        20.3.1. By Country

            20.3.1.1. GCC Countries

            20.3.1.2. South Africa

            20.3.1.3. Rest of MEA

                20.3.1.3.1. By Product 

                20.3.1.3.2. By Application

                20.3.1.3.3. By Molecule Type

                20.3.1.3.4. Route of administration

                20.3.1.3.5. By Distribution Channel

    20.4. Market Attractiveness Analysis

        20.4.1. By Country

        20.4.2. By Product 

        20.4.3. By Distribution Channel

    20.5. Country Level Analysis & Forecast

        20.5.1. GCC Countries Global Market

            20.5.1.1. Introduction

            20.5.1.2. Market Analysis and Forecast by Market Taxonomy

                20.5.1.2.1. By Product 

                20.5.1.2.2. By Application

                20.5.1.2.3. By Molecule Type

                20.5.1.2.4. Route of administration

                20.5.1.2.5. By Distribution Channel

        20.5.2. South Africa Countries Market

            20.5.2.1. Introduction

            20.5.2.2. Market Analysis and Forecast by Market Taxonomy

                20.5.2.2.1. By Product 

                20.5.2.2.2. By Application

                20.5.2.2.3. By Molecule Type

                20.5.2.2.4. Route of administration

                20.5.2.2.5. By Distribution Channel

21. Market Structure Analysis

    21.1. Market Analysis by Tier of Companies (Global Injectable Drugs)

    21.2. Market Concentration

    21.3. Market Share Analysis of Top Players

    21.4. Market Presence Analysis

22. Competition Analysis

    22.1. Competition Dashboard

    22.2. Competition Benchmarking

    22.3. Competition Deep Dive 

            22.3.1.1. Novartis

                22.3.1.1.1. Overview

                22.3.1.1.2. Product Portfolio

                22.3.1.1.3. Recent Developments

                22.3.1.1.4. Regional Footprint

                22.3.1.1.5. Strategy Overview

                22.3.1.1.6. SWOT Analysis

            22.3.1.2. Pfizer Inc., 

                22.3.1.2.1. Overview

                22.3.1.2.2. Product Portfolio

                22.3.1.2.3. Recent Developments

                22.3.1.2.4. Regional Footprint

                22.3.1.2.5. Strategy Overview

                22.3.1.2.6. SWOT Analysis

            22.3.1.3. Teva Pharmaceutical Industries Ltd. 

                22.3.1.3.1. Overview

                22.3.1.3.2. Product Portfolio

                22.3.1.3.3. Recent Developments

                22.3.1.3.4. Regional Footprint

                22.3.1.3.5. Strategy Overview

                22.3.1.3.6. SWOT Analysis

            22.3.1.4. Sanofi S.A. 

                22.3.1.4.1. Overview

                22.3.1.4.2. Product Portfolio

                22.3.1.4.3. Recent Developments

                22.3.1.4.4. Regional Footprint

                22.3.1.4.5. Strategy Overview

                22.3.1.4.6. SWOT Analysis

            22.3.1.5. Sun Pharmaceutical Industries Ltd. 

                22.3.1.5.1. Overview

                22.3.1.5.2. Product Portfolio

                22.3.1.5.3. Recent Developments

                22.3.1.5.4. Regional Footprint

                22.3.1.5.5. Strategy Overview

                22.3.1.5.6. SWOT Analysis

            22.3.1.6. AstraZeneca Plc

                22.3.1.6.1. Overview

                22.3.1.6.2. Product Portfolio

                22.3.1.6.3. Recent Developments

                22.3.1.6.4. Regional Footprint

                22.3.1.6.5. Strategy Overview

                22.3.1.6.6. SWOT Analysis 

            22.3.1.7. Merck & Co., Inc.

                22.3.1.7.1. Overview

                22.3.1.7.2. Product Portfolio

                22.3.1.7.3. Recent Developments

                22.3.1.7.4. Regional Footprint

                22.3.1.7.5. Strategy Overview

                22.3.1.7.6. SWOT Analysis 

            22.3.1.8. Viatris + Mylan N.V

                22.3.1.8.1. Overview

                22.3.1.8.2. Product Portfolio

                22.3.1.8.3. Recent Developments

                22.3.1.8.4. Regional Footprint

                22.3.1.8.5. Strategy Overview

                22.3.1.8.6. SWOT Analysis

            22.3.1.9. Cipla Inc. 

                22.3.1.9.1. Overview

                22.3.1.9.2. Product Portfolio

                22.3.1.9.3. Recent Developments

                22.3.1.9.4. Regional Footprint

                22.3.1.9.5. Strategy Overview

                22.3.1.9.6. SWOT Analysis

            22.3.1.10. Dr. Reddy’s Laboratories Ltd. 

                22.3.1.10.1. Overview

                22.3.1.10.2. Product Portfolio

                22.3.1.10.3. Recent Developments

                22.3.1.10.4. Regional Footprint

                22.3.1.10.5. Strategy Overview

                22.3.1.10.6. SWOT Analysis

            22.3.1.11. Samsung Biologics

                22.3.1.11.1. Overview

                22.3.1.11.2. Product Portfolio

                22.3.1.11.3. Recent Developments

                22.3.1.11.4. Regional Footprint

                22.3.1.11.5. Strategy Overview

                22.3.1.11.6. SWOT Analysis

            22.3.1.12. Abbott Laboratories

                22.3.1.12.1. Overview

                22.3.1.12.2. Product Portfolio

                22.3.1.12.3. Recent Developments

                22.3.1.12.4. Regional Footprint

                22.3.1.12.5. Strategy Overview

                22.3.1.12.6. SWOT Analysis

            22.3.1.13. Amgen Incorporated

                22.3.1.13.1. Overview

                22.3.1.13.2. Product Portfolio

                22.3.1.13.3. Recent Developments

                22.3.1.13.4. Regional Footprint

                22.3.1.13.5. Strategy Overview

                22.3.1.13.6. SWOT Analysis

            22.3.1.14. Baxter International Incorporated

                22.3.1.14.1. Overview

                22.3.1.14.2. Product Portfolio

                22.3.1.14.3. Recent Developments

                22.3.1.14.4. Regional Footprint

                22.3.1.14.5. Strategy Overview

                22.3.1.14.6. SWOT Analysis

            22.3.1.15. Becton, Dickinson and Company

                22.3.1.15.1. Overview

                22.3.1.15.2. Product Portfolio

                22.3.1.15.3. Recent Developments

                22.3.1.15.4. Regional Footprint

                22.3.1.15.5. Strategy Overview

                22.3.1.15.6. SWOT Analysis

            22.3.1.16. Bristol-Myers Squibb Company

                22.3.1.16.1. Overview

                22.3.1.16.2. Product Portfolio

                22.3.1.16.3. Recent Developments

                22.3.1.16.4. Regional Footprint

                22.3.1.16.5. Strategy Overview

                22.3.1.16.6. SWOT Analysis

            22.3.1.17. GlaxoSmithKline Plc

                22.3.1.17.1. Overview

                22.3.1.17.2. Product Portfolio

                22.3.1.17.3. Recent Developments

                22.3.1.17.4. Regional Footprint

                22.3.1.17.5. Strategy Overview

                22.3.1.17.6. SWOT Analysis

            22.3.1.18. Roche Holding Limited.

                22.3.1.18.1. Overview

                22.3.1.18.2. Product Portfolio

                22.3.1.18.3. Recent Developments

                22.3.1.18.4. Regional Footprint

                22.3.1.18.5. Strategy Overview

                22.3.1.18.6. SWOT Analysis

23. Assumptions and Acronyms Used

24. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Market Size Value (US$ Bn) Analysis 2014-2021 and Forecast 2022–2032 , by Product Type

Table 02: Global Market Size Value (US$ Bn) Analysis 2014-2021 and Forecast 2022–2032 , by Application

Table 03: Global Market Size Value (US$ Bn) Analysis 2014-2021 and Forecast 2022–2032 , by Molecule Type

Table 04: Global Market Size Value (US$ Bn) Analysis 2014-2021 and Forecast 2022–2032 , by Route of Administration

Table 05: Global Market Size Value (US$ Bn) Analysis 2014-2021 and Forecast 2022–2032 , by Distribution Channel

Table 06: Global Market Size Value (US$ Bn) Analysis 2014-2021 and Forecast 2022–2032 , by Region

Table 07: North America Market Size (US$ Bn) Analysis-2014-2021 and Forecast 2022-2032 by Country

Table 08: North America Market Size (US$ Bn) Analysis-2014-2021 and Forecast 2022-2032 by Product Type

Table 09: North America Market Size (US$ Bn) Analysis-2014-2021 and Forecast 2022-2032 by Application

Table 10: North America Market Size (US$ Bn) Analysis-2014-2021 and Forecast 2022-2032 by Molecule Type

Table 11: North America Market Size (US$ Bn) Analysis-2014-2021 and Forecast 2022-2032 by Route of Administration

Table 12: North America Market Size (US$ Bn) Analysis-2014-2021 and Forecast 2022-2032 by Distribution Channel

Table 13: Latin America Market Size (US$ Bn) Analysis-2014-2021 and Forecast 2022-2032 by Country

Table 14: Latin America Market Size (US$ Bn) Analysis-2014-2021 and Forecast 2022-2032 by Product Type

Table 15: Latin America Market Size (US$ Bn) Analysis-2014-2021 and Forecast 2022-2032 by Application

Table 16: Latin America Market Size (US$ Bn) Analysis-2014-2021 and Forecast 2022-2032 by Molecule Type

Table 17: Latin America Market Size (US$ Bn) Analysis-2014-2021 and Forecast 2022-2032 by Route of Administration

Table 18: Latin America Market Size (US$ Bn) Analysis-2014-2021 and Forecast 2022-2032 by Distribution Channel

Table 19: Europe Market Size (US$ Bn) Analysis-2014-2021 and Forecast 2022-2032 by Country

Table 20: Europe Market Size (US$ Bn) Analysis-2014-2021 and Forecast 2022-2032 by Product Type

Table 21: Europe Market Size (US$ Bn) Analysis-2014-2021 and Forecast 2022-2032 by Application

Table 22: Europe Market Size (US$ Bn) Analysis-2014-2021 and Forecast 2022-2032 by Molecule Type

Table 23: Europe Market Size (US$ Bn) Analysis-2014-2021 and Forecast 2022-2032 by Route of Administration

Table 24: Europe Market Size (US$ Bn) Analysis-2014-2021 and Forecast 2022-2032 by Distribution Channel

Table 25: South Asia Market Size (US$ Bn) Analysis-2014-2021 and Forecast 2022-2032 by Country

Table 26: South Asia Market Size (US$ Bn) Analysis-2014-2021 and Forecast 2022-2032 by Product Type

Table 27: South Asia Market Size (US$ Bn) Analysis-2014-2021 and Forecast 2022-2032 by Application

Table 28: South Asia Market Size (US$ Bn) Analysis-2014-2021 and Forecast 2022-2032 by Molecule Type

Table 29: South Asia Market Size (US$ Bn) Analysis-2014-2021 and Forecast 2022-2032 by Route of Administration

Table 30: South Asia Market Size (US$ Bn) Analysis-2014-2021 and Forecast 2022-2032 by Distribution Channel

Table 31: East Asia Market Size (US$ Bn) Analysis-2014-2021 and Forecast 2022-2032 by Country

Table 32: East Asia Market Size (US$ Bn) Analysis-2014-2021 and Forecast 2022-2032 by Product Type

Table 33: East Asia Market Size (US$ Bn) Analysis-2014-2021 and Forecast 2022-2032 by Application

Table 34: East Asia Market Size (US$ Bn) Analysis-2014-2021 and Forecast 2022-2032 by Molecule Type

Table 35: East Asia Market Size (US$ Bn) Analysis-2014-2021 and Forecast 2022-2032 by Route of Administration

Table 36: East Asia Market Size (US$ Bn) Analysis-2014-2021 and Forecast 2022-2032 by Distribution Channel

Table 37: Oceania Market Size (US$ Bn) Analysis-2014-2021 and Forecast 2022-2032 by Country

Table 38: Oceania Market Size (US$ Bn) Analysis-2014-2021 and Forecast 2022-2032 by Product Type

Table 39: Oceania Market Size (US$ Bn) Analysis-2014-2021 and Forecast 2022-2032 by Application

Table 40: Oceania Market Size (US$ Bn) Analysis-2014-2021 and Forecast 2022-2032 by Molecule Type

Table 41: Oceania Market Size (US$ Bn) Analysis-2014-2021 and Forecast 2022-2032 by Route of Administration

Table 42: Oceania Market Size (US$ Bn) Analysis-2014-2021 and Forecast 2022-2032 by Distribution Channel

Table 43: MEA Market Size (US$ Bn) Analysis-2014-2021 and Forecast 2022-2032 by Country

Table 44: MEA Market Size (US$ Bn) Analysis-2014-2021 and Forecast 2022-2032 by Product Type

Table 45: MEA Market Size (US$ Bn) Analysis-2014-2021 and Forecast 2022-2032 by Application

Table 46: MEA Market Size (US$ Bn) Analysis-2014-2021 and Forecast 2022-2032 by Molecule Type

Table 47: MEA Market Size (US$ Bn) Analysis-2014-2021 and Forecast 2022-2032 by Route of Administration

Table 48: MEA Market Size (US$ Bn) Analysis-2014-2021 and Forecast 2022-2032 by Distribution Channel

Table 1A: Number of Clinical Trials

Table 1B: Number of Clinical Trials

Table 1C: Number of Clinical Trials

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Market Value Share, by Product Type (2022 E)

Figure 02: Global Market Value Share, by Molecule Type (2022 E)

Figure 03: Global Market Value Share, by Application (2022 E)

Figure 04: Global Market Value Share, by Route of Administration (2022 E)

Figure 05: Global Market Value Share, by Distribution Channel (2022 E)

Figure 06: Estimated number of people with diabetes and prevalence of diabetes in adults (20–79 years) in IDF Regions in 2021

Figure 07: Estimated number of people with diabetes and prevalence of diabetes in adults (20–79 years) in IDF Regions in 2045

Figure 08: North America, Estimated new Cases, 2020

Figure 09: Europe, Estimated New cases, 2020

Figure 10: Asia, Estimated new Cases, 2020

Figure 11: Latin America & Caribbean, Estimated new Cases, 2020

Figure 12: Oceania, Estimated New cases, 2020

Figure 13: Africa, Estimated new Cases, 2020

Figure 14: Pipeline Products Share (%), by main Therapeutic Area (2017-2022) 

Figure 15: Percentage of Registered Studies by Location (as of April 07, 2022)

Figure 16: Percentage of Recruiting Studies by Location (as of April 07, 2022)

Figure 17: Types of Registered Studies

Figure 18: Number of Registered Studies by Year (2017-2022)

Figure 19: Global Market Value Analysis and Forecast, 2022–2032 (US$ Bn)

Figure 20: Global Market Absolute $ Opportunity (US$ Bn), 2014-2021

Figure 21: Global Market Absolute $ Opportunity (US$ Bn), 2022–2032

Figure 22: Global Market Share Analysis (%) by Product Type, 2022 & 2032 

Figure 23: Global Market Y-o-Y Growth (%) by Product Type, 2022–2032

Figure 24: Global Market Attractiveness Analysis by Product Type, 2022–2032 

Figure 25: Global Market Share Analysis (%) by Application, 2022 & 2032 

Figure 26: Global Market Y-o-Y Growth (%) by Application, 2022–2032

Figure 27: Global Market Attractiveness Analysis by Application, 2022–2032 

Figure 28: Global Market Share Analysis (%) by Molecule Type, 2022 & 2032 

Figure 29: Global Market Y-o-Y Growth (%) by Molecule Type, 2022–2032

Figure 30: Global Market Attractiveness Analysis by Molecule Type, 2022–2032 

Figure 31: Global Market Share Analysis (%) by Route of Administration, 2022 & 2032 

Figure 32: Global Market Y-o-Y Growth (%) by Route of Administration, 2022–2032

Figure 33: Global Market Attractiveness Analysis by Route of Administration, 2022–2032 

Figure 34: Global Market Share Analysis (%) by Distribution Channel, 2022 & 2032 

Figure 35: Global Market Y-o-Y Growth (%) by Distribution Channel, 2022–2032

Figure 36: Global Market Attractiveness Analysis by Distribution Channel, 2022–2032 

Figure 37: Global Market Share Analysis (%) by Region, 2022 & 2032 

Figure 38: Global Market Y-o-Y Growth (%) by Region, 2022–2032

Figure 39: Global Market Attractiveness Analysis by Region, 2022–2032 

Figure 40: North America Market Size Analysis, 2014-2021

Figure 41: North America Market Forecast & Y-o-Y growth, 2022–2032

Figure 42: North America Market Attractiveness Analysis by Country, 2022-2032

Figure 43: North America Market Attractiveness Analysis by Product Type, 2022-2032

Figure 44: North America Market Attractiveness Analysis by Application, 2022-2032

Figure 45: North America Market Attractiveness Analysis by Molecule Type, 2022-2032

Figure 46: North America Market Attractiveness Analysis by Route of Administration, 2022-2032

Figure 47: North America Market Attractiveness Analysis by Distribution Channel, 2022-2032

Figure 48: US Market Value Proportion Analysis (2022)

Figure 49: Global Vs. U.S. Growth Comparison

Figure 50: US Market Share Analysis (%) by Product Type, 2022 & 2032

Figure 51: US Market Share Analysis (%) by Application, 2022 & 2032

Figure 52: US Market Share Analysis (%) by Molecule Type, 2022 & 2032

Figure 53: US Market Share Analysis (%) by Route of Administration, 2022 & 2032

Figure 54: US Market Share Analysis (%) by Distribution Channel, 2022 & 2032

Figure 55: Canada Market Value Proportion Analysis (2022)

Figure 56: Global Vs. Canada Growth Comparison

Figure 57: Canada Market Share Analysis (%) by Product Type, 2022 & 2032

Figure 58: Canada Market Share Analysis (%) by Application, 2022 & 2032

Figure 59: Canada Market Share Analysis (%) by Molecule Type, 2022 & 2032

Figure 60: Canada Market Share Analysis (%) by Route of Administration, 2022 & 2032

Figure 61: Canada Market Share Analysis (%) by Distribution Channel, 2022 & 2032

Figure 62: Latin America Market Size Analysis, 2014-2021

Figure 63: Latin America Market Forecast & Y-o-Y growth, 2022–2032

Figure 64: Latin America Market Attractiveness Analysis by Country, 2022-2032

Figure 65: Latin America Market Attractiveness Analysis by Product Type, 2022-2032

Figure 66: Latin America Market Attractiveness Analysis by Application, 2022-2032

Figure 67: Latin America Market Attractiveness Analysis by Molecule Type, 2022-2032

Figure 68: Latin America Market Attractiveness Analysis by Route of Administration, 2022-2032

Figure 69: Latin America Market Attractiveness Analysis by Distribution Channel, 2022-2032

Figure 70: Brazil Market Value Proportion Analysis (2022)

Figure 71: Global Vs. Brazil Growth Comparison

Figure 72: Brazil Market Share Analysis (%) by Product Type, 2022 & 2032

Figure 73: Brazil Market Share Analysis (%) by Application, 2022 & 2032

Figure 74: Brazil Market Share Analysis (%) by Molecule Type, 2022 & 2032

Figure 75: Brazil Market Share Analysis (%) by Route of Administration, 2022 & 2032

Figure 76: Brazil Market Share Analysis (%) by Distribution Channel, 2022 & 2032

Figure 77: Mexico Market Value Proportion Analysis (2022)

Figure 78: Global Vs. Mexico Growth Comparison

Figure 79: Mexico Market Share Analysis (%) by Product Type, 2022 & 2032

Figure 80: Mexico Market Share Analysis (%) by Application, 2022 & 2032

Figure 81: Mexico Market Share Analysis (%) by Molecule Type, 2022 & 2032

Figure 82: Mexico Market Share Analysis (%) by Route of Administration, 2022 & 2032

Figure 83: Mexico Market Share Analysis (%) by Distribution Channel, 2022 & 2032

Figure 84: Argentina Market Value Proportion Analysis (2022)

Figure 85: Global Vs. Argentina Growth Comparison

Figure 86: Argentina Market Share Analysis (%) by Product Type, 2022 & 2032

Figure 87: Argentina Market Share Analysis (%) by Application, 2022 & 2032

Figure 88: Argentina Market Share Analysis (%) by Molecule Type, 2022 & 2032

Figure 89: Argentina Market Share Analysis (%) by Route of Administration, 2022 & 2032

Figure 90: Argentina Market Share Analysis (%) by Distribution Channel, 2022 & 2032

Figure 91: Europe Market Size Analysis, 2014-2021

Figure 92: Europe Market Forecast & Y-o-Y growth, 2022–2032

Figure 93: Europe Market Attractiveness Analysis by Country, 2022-2032

Figure 94: Europe Market Attractiveness Analysis by Product Type, 2022-2032

Figure 95: Europe Market Attractiveness Analysis by Application, 2022-2032

Figure 96: Europe Market Attractiveness Analysis by Molecule Type, 2022-2032

Figure 97: Europe Market Attractiveness Analysis by Route of Administration, 2022-2032

Figure 98: Europe Market Attractiveness Analysis by Distribution Channel, 2022-2032

Figure 99: Germany Market Value Proportion Analysis (2022)

Figure 100: Global Vs. Germany Growth Comparison

Figure 101: Germany Market Share Analysis (%) by Product Type, 2022 & 2032

Figure 102: Germany Market Share Analysis (%) by Application, 2022 & 2032

Figure 103: Germany Market Share Analysis (%) by Molecule Type, 2022 & 2032

Figure 104: Germany Market Share Analysis (%) by Route of Administration, 2022 & 2032

Figure 105: Germany Market Share Analysis (%) by Distribution Channel, 2022 & 2032

Figure 106: Italy Market Value Proportion Analysis (2022)

Figure 107: Global Vs. Italy Growth Comparison

Figure 108: Italy Market Share Analysis (%) by Product Type, 2022 & 2032

Figure 109: Italy Market Share Analysis (%) by Application, 2022 & 2032

Figure 110: Italy Market Share Analysis (%) by Molecule Type, 2022 & 2032

Figure 111: Italy Market Share Analysis (%) by Route of Administration, 2022 & 2032

Figure 112: Italy Market Share Analysis (%) by Distribution Channel, 2022 & 2032

Figure 113: France Market Value Proportion Analysis (2022)

Figure 114: Global Vs. France Growth Comparison

Figure 115: France Market Share Analysis (%) by Product Type, 2022 & 2032

Figure 116: France Market Share Analysis (%) by Application, 2022 & 2032

Figure 117: France Market Share Analysis (%) by Molecule Type, 2022 & 2032

Figure 118: France Market Share Analysis (%) by Route of Administration, 2022 & 2032

Figure 119: France Market Share Analysis (%) by Distribution Channel, 2022 & 2032

Figure 120: U.K. Market Value Proportion Analysis (2022)

 Figure 121: Global Vs. U.K. Growth Comparison

Figure 122: U.K. Market Share Analysis (%) by Product Type, 2022 & 2032

Figure 123: U.K. Market Share Analysis (%) by Application, 2022 & 2032

Figure 124: U.K. Market Share Analysis (%) by Molecule Type, 2022 & 2032

Figure 125: U.K. Market Share Analysis (%) by Route of Administration, 2022 & 2032

Figure 126: U.K. Market Share Analysis (%) by Distribution Channel, 2022 & 2032

Figure 127: Spain Market Value Proportion Analysis (2022)

Figure 128: Global Vs. Spain Growth Comparison

Figure 129: Spain Market Share Analysis (%) by Product Type, 2022 & 2032

Figure 130: Spain Market Share Analysis (%) by Application, 2022 & 2032

Figure 131: Spain Market Share Analysis (%) by Molecule Type, 2022 & 2032

Figure 132: Spain Market Share Analysis (%) by Route of Administration, 2022 & 2032

Figure 133: Spain Market Share Analysis (%) by Distribution Channel, 2022 & 2032

Figure 134: Benelux Market Value Proportion Analysis (2022)

Figure 135: Global Vs. BENELUX Growth Comparison

Figure 136: Benelux Market Share Analysis (%) by Product Type, 2022 & 2032

Figure 137: Benelux Market Share Analysis (%) by Application, 2022 & 2032

Figure 138: Benelux Market Share Analysis (%) by Molecule Type, 2022 & 2032

Figure 139: Benelux Market Share Analysis (%) by Route of Administration, 2022 & 2032

Figure 140: Benelux Market Share Analysis (%) by Distribution Channel, 2022 & 2032

Figure 141: Russia Market Value Proportion Analysis (2022)

Figure 142: Global Vs. U.S. Growth Comparison

Figure 143: Russia Market Share Analysis (%) by Product Type, 2022 & 2032

Figure 144: Russia Market Share Analysis (%) by Application, 2022 & 2032

Figure 145: Russia Market Share Analysis (%) by Molecule Type, 2022 & 2032

Figure 146: Russia Market Share Analysis (%) by Route of Administration, 2022 & 2032

Figure 147: Russia Market Share Analysis (%) by Distribution Channel, 2022 & 2032

Figure 148: South Asia Market Size Analysis, 2014-2021

Figure 149: South Asia Market Forecast & Y-o-Y growth 2022–2032

Figure 150: South Asia Market Attractiveness Analysis by Country, 2022-2032

Figure 151: South Asia Market Attractiveness Analysis by Product Type, 2022-2032

Figure 152: South Asia Market Attractiveness Analysis by Application, 2022-2032

Figure 153: South Asia Market Attractiveness Analysis by Molecule Type, 2022-2032

Figure 154: South Asia Market Attractiveness Analysis by Route of Administration, 2022-2032

Figure 155: South Asia Market Attractiveness Analysis by Distribution Channel, 2022-2032

Figure 156: India Market Value Proportion Analysis (2022)

Figure 157: Global Vs. India Growth Comparison

 Figure 158: India Market Share Analysis (%) by Product Type, 2022 & 2032

Figure 159: India Market Share Analysis (%) by Application, 2022 & 2032

Figure 160: India Market Share Analysis (%) by Molecule Type, 2022 & 2032

Figure 161: India Market Share Analysis (%) by Route of Administration, 2022 & 2032

Figure 162: India Market Share Analysis (%) by Distribution Channel, 2022 & 2032

Figure 163: Thailand Market Value Proportion Analysis (2022)

Figure 164: Global Vs. Thailand Growth Comparison

Figure 165: Thailand Market Share Analysis (%) by Product Type, 2022 & 2032

Figure 166: Thailand Market Share Analysis (%) by Application, 2022 & 2032

Figure 167: Thailand Market Share Analysis (%) by Molecule Type, 2022 & 2032

Figure 168: Thailand Market Share Analysis (%) by Route of Administration, 2022 & 2032

Figure 169: Thailand Market Share Analysis (%) by Distribution Channel, 2022 & 2032

Figure 170: Malaysia Market Value Proportion Analysis (2022)

Figure 171: Global Vs. Malaysia Growth Comparison

Figure 172: Malaysia Market Share Analysis (%) by Product Type, 2022 & 2032

Figure 173: Malaysia Market Share Analysis (%) by Application, 2022 & 2032

Figure 174: Malaysia Market Share Analysis (%) by Molecule Type, 2022 & 2032

Figure 175: Malaysia Market Share Analysis (%) by Route of Administration, 2022 & 2032

Figure 176: Malaysia Market Share Analysis (%) by Distribution Channel, 2022 & 2032

Figure 177: East Asia Market Size Analysis, 2014-2021

Figure 178: East Asia Market Forecast & Y-o-Y growth, 2022–2032

Figure 179: East Asia Market Attractiveness Analysis by Country, 2022-2032

Figure 180: East Asia Market Attractiveness Analysis by Product Type, 2022-2032

Figure 181: East Asia Market Attractiveness Analysis by Application, 2022-2032

Figure 182: East Asia Market Attractiveness Analysis by Molecule Type, 2022-2032

Figure 183: East Asia Market Attractiveness Analysis by Route of Administration, 2022-2032

Figure 184: East Asia Market Attractiveness Analysis by Distribution Channel, 2022-2032

Figure 185: China Market Value Proportion Analysis (2022)

Figure 186: Global Vs. China Growth Comparison

Figure 187: China Market Share Analysis (%) by Product Type, 2022 & 2032

Figure 188: China Market Share Analysis (%) by Application, 2022 & 2032

Figure 189: China Market Share Analysis (%) by Route of Administration, 2022 & 2032

Figure 190: China Market Share Analysis (%) by Distribution Channel, 2022 & 2032

Figure 191: Japan Market Value Proportion Analysis (2022)

Figure 192: Global Vs. Japan Growth Comparison

Figure 193: Japan Market Share Analysis (%) by Product Type, 2022 & 2032

Figure 194: Japan Market Share Analysis (%) by Application, 2022 & 2032

Figure 195: Japan Market Share Analysis (%) by Molecule Type, 2022 & 2032

Figure 196: Japan Market Share Analysis (%) by Route of Administration, 2022 & 2032

Figure 197: Japan Market Share Analysis (%) by Distribution Channel, 2022 & 2032

Figure 198: South Korea Market Value Proportion Analysis (2022)

Figure 199: Global Vs. South Korea Growth Comparison

Figure 200: South Korea Market Share Analysis (%) by Product Type, 2022 & 2032

Figure 201: South Korea Market Share Analysis (%) by Application, 2022 & 2032

Figure 202: South Korea Market Share Analysis (%) by Molecule Type, 2022 & 2032

Figure 203: South Korea Market Share Analysis (%) by Route of Administration, 2022 & 2032

Figure 204: South Korea Market Share Analysis (%) by Distribution Channel, 2022 & 2032

Figure 205: Oceania Market Size Analysis, 2014-2021

Figure 206: Oceania Market Forecast & Y-o-Y growth, 2022–2032

Figure 207: Oceania Market Attractiveness Analysis by Country, 2022-2032

Figure 208: Oceania Market Attractiveness Analysis by Product Type, 2022-2032

Figure 209: Oceania Market Attractiveness Analysis by Application, 2022-2032

Figure 210: Oceania Market Attractiveness Analysis by Molecule Type, 2022-2032

Figure 211: Oceania Market Attractiveness Analysis by Route of Administration, 2022-2032

Figure 212: Oceania Market Attractiveness Analysis by Distribution Channel, 2022-2032

Figure 213: Australia Market Value Proportion Analysis (2022)

Figure 214: Global Vs. Australia Growth Comparison

Figure 215: Australia Market Share Analysis (%) by Product Type, 2022 & 2032

Figure 216: Australia Market Share Analysis (%) by Application, 2022 & 2032

Figure 217: Australia Market Share Analysis (%) by Molecule Type, 2022 & 2032

Figure 218: Australia Market Share Analysis (%) by Route of Administration, 2022 & 2032

Figure 219: Australia Market Share Analysis (%) by Distribution Channel, 2022 & 2032

Figure 220: New Zealand Market Value Proportion Analysis (2022)

Figure 221: Global Vs. New Zealand Growth Comparison

Figure 222: New Zealand Market Share Analysis (%) by Product Type, 2022 & 2032

Figure 223: New Zealand Market Share Analysis (%) by Application, 2022 & 2032

Figure 224: New Zealand Market Share Analysis (%) by Molecule Type, 2022 & 2032

 Figure 225: New Zealand Market Share Analysis (%) by Route of Administration, 2022 & 2032

Figure 226: MEA Market Size Analysis, 2014-2021

Figure 227: MEA Market Forecast & Y-o-Y growth, 2022–2032

Figure 228: MEA Market Attractiveness Analysis by Country, 2022-2032

Figure 229: MEA Market Attractiveness Analysis by Product Type, 2022-2032

Figure 230: MEA Market Attractiveness Analysis by Application, 2022-2032

Figure 231: MEA Market Attractiveness Analysis by Molecule Type, 2022-2032

Figure 232: MEA Market Attractiveness Analysis by Route of Administration, 2022-2032

Figure 233: MEA Market Attractiveness Analysis by Distribution Channel, 2022-2032

Figure 234: GCC Countries Market Value Proportion Analysis (2022)

Figure 235: Global Vs. GCC Countries Growth Comparison

Figure 236: GCC Countries Market Share Analysis (%) by Product Type, 2022 & 2032

Figure 237: GCC Countries Market Share Analysis (%) by Application, 2022 & 2032

Figure 238: GCC Countries Market Share Analysis (%) by Molecule Type, 2022 & 2032

Figure 239: GCC Countries Market Share Analysis (%) by Route of Administration, 2022 & 2032

Figure 240: GCC Countries Market Share Analysis (%) by Distribution Channel, 2022 & 2032

Figure 241: South Africa Market Value Proportion Analysis (2022)

Figure 242: Global Vs. South Africa Growth Comparison

Figure 243: South Africa Market Share Analysis (%) by Product Type, 2022 & 2032

Figure 244: South Africa Market Share Analysis (%) by Application, 2022 & 2032

Figure 245: South Africa Market Share Analysis (%) by Molecule Type, 2022 & 2032

Figure 246: South Africa Market Share Analysis (%) by Route of Administration, 2022 & 2032

Figure 247: South Africa Market Share Analysis (%) by Distribution Channel, 2022 & 2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Extended Release Drugs Market

Published : June 2019

Healthcare

Microneedle Drug Delivery Systems Market

Published : November 2020

Healthcare

Systemic Lupus Erythematous SLE Drugs Market

Published : March 2022

Healthcare

Injectable Drug Delivery Market

Published : December 2021

Google translate

Injectable Drugs Market